Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention and Chairs the Acute Myocardial Infarction(STEMI)Committee for the cardiac cath lab. He is a national leader in treatment of Carotid, Kidney, and Leg artery disease.




Centers & Specialties

Heart Center

Vascular Center

Clinical Interests
  • Renal/Mesenteric and extremities revascularization
  • Fibromuscular dysplasia (FMD)
  • Takayasu arteritis (TA)
  • Peripheral artery disease of the legs
  • Resistant Hypertension
  • Spontaneous coronary artery dissection (SCAD)
Medical Education
  • MD, University of Massachusetts Medical School
  • Residency, Kaiser Permanente Medical Center
  • Fellowship, St. Elizabeth's Medical Center|Fellowship, Tufts Medical Center
Board Certifications
  • Cardiovascular Disease
  • Internal Medicine
  • Interventional Cardiology
  • Boston: Massachusetts General Hospital
  • Waltham: Mass General West
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention, who specializes in complex cardiac and vascular interventions and directs the program for treatment of acute myocardial infarction (STEMI) in the cardiac catheterization laboratories. He has spearheaded the development of less-invasive therapies for patients with coronary and vascular disease, both at MGH and nationally, including treatment of Carotid, Kidney, and Leg artery narrowing using stents and other novel devices.

Edit Profile

Research & Publications

Research Summary
Dr. Rosenfield has served as national principle investigator (PI) for numerous clinical trials

Edit Profile

News & Events

  • First U.S.-based trial supports the effectiveness of a drug-coated balloon for patients with PAD

    In January 2015, the U.S. FDA approved the use of a drug-coated balloon to treat peripheral artery disease (PAD) based on research spearheaded by Kenneth Rosenfield, MD, and Michael R. Jaff, DO.

  • Harnessing the power of PERT

    The MGH recently hosted a scientific symposium, "Pulmonary Embolism: What Is Known, What We Need To Know" to discuss improvements in PE detection, care coordination and patient management.

  • Boston Hospital Trio Awarded $25 Million NIH Grant to Study Critical Limb Ischemia

    A team of researchers from Brigham and Women's Hospital, Boston Medical Center and MGH has been awarded $25 million by the National Institutes of Health to conduct a clinical trial comparing traditional bypass surgery with a less invasive treatment alternative for patients with critical limb ischemia.

  • Novel Therapeutic Strategies for Systemic Cardiovascular Disease

    Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present a dynamic symposium on systemic cardiovascular disease.

  • Seconds count

    MGH Hotline 4.1.11 From the time a person first experiences symptoms of a heart attack, such as shortness of breath or chest discomfort, to the time he or she undergoes cardiac catheterization -- a procedure used to diagnose and treat a blocked coronary artery -- every second is of utmost importance.

  • VIVA Las Vegas

    Mass General Heart & Vascular Center physicians perform demonstrations of complex vascular interventions for an educational conference in Las Vegas.

  • Patient selection criteria and interventional treatment parameters for renal artery stenosis

    The medical community has made great strides treating coronary and carotid artery diseases and reducing mortality associated with myocardial infarctions and strokes. While as many as 3 million Americans have renal artery stenosis (RAS)—a condition that narrows or blocks the vessels that supply blood to the kidneys—RAS is often overlooked and underdiagnosed.

  • Stents and surgery both safe for prevention of stroke, study says

    Investigators from Massachusetts General Hospital revealed the results of the CREST trial, a study that looked at the efficacy of carotid endarterectomy versus stenting in patients with symptomatic carotid stenosis, and found that these two medical procedures are both equally safe and effective.

  • Miracle patient revived after 57 minutes

    Mass General Hospital physician, Kenneth Rosenfield, MD, attributes Laura Geraghty's heart attack recovery to immediate and effective CPR. Now Rosenfield and Geraghty are advocating for CPR instruction in Massachusetts high schools.


Interventional Cardiology Associates
55 Fruit Street
Boston MA, 02114
Phone: 617-726-2256617-724-1935
Fax: 617-726-3971

Edit Profile